Key result
Engineered biomaterial environments mimicking early calcific aortic valve disease showed that hyaluronic acid increased VEGF production and chondroitin sulfate retained lipoproteins like oxLDL.
Answers are grounded in this paper and cite their sources.
Engineered biomaterial environments mimicking early calcific aortic valve disease demonstrate that specific glycosaminoglycans and oxidized LDL interact to drive a positive feedback loop of valve lesion progression.
An insufficient understanding of calcific aortic valve disease (CAVD) pathogenesis remains a major obstacle in developing treatment strategies for this disease. The aim of the present study was to create engineered environments that mimic the earliest known features of CAVD and apply this in vitro platform to decipher relationships relevant to early valve lesion pathobiology. Glycosaminoglycan (GAG) enrichment is a dominant hallmark of early CAVD, but culture of valvular interstitial cells (VICs) in biomaterial environments containing pathological amounts of hyaluronic acid (HA) or chondroitin sulfate (CS) did not directly increase indicators of disease progression such as VIC activation or inflammatory cytokine production. However, HA-enriched matrices increased production of vascular endothelial growth factor (VEGF), while matrices displaying pathological levels of CS were effective at retaining lipoproteins, whose deposition is also found in early CAVD. Retained oxidized low-density lipoprotein (oxLDL), in turn, stimulated myofibroblastic VIC differentiation and secretion of numerous inflammatory cytokines. OxLDL also increased VIC deposition of GAGs, thereby creating a positive feedback loop to further enrich GAG content and promote disease progression. Using this disease-inspired in vitro platform, we were able to model a complex, multistep pathological sequence, with our findings suggesting distinct roles for individual GAGs in outcomes related to valve lesion progression, as well as key differences in cell-lipoprotein interactions compared with atherosclerosis. We propose a pathogenesis cascade that may be relevant to understanding early CAVD and envision the extension of such models to investigate other tissue pathologies or test pharmacological treatments.
No takes yet. Share an insight, caveat, or question.
Porras et al. (2017) studied calcific aortic valve disease (CAVD). biomaterial environments containing pathological amounts of hyaluronic acid (HA) or chondroitin sulfate (CS) was evaluated on indicators of disease progression (VIC activation, inflammatory cytokine production, VEGF production, lipoprotein retention). Engineered biomaterial environments mimicking early calcific aortic valve disease showed that hyaluronic acid increased VEGF production and chondroitin sulfate retained lipoproteins like oxLDL.
Synapse has enriched 10 related papers. Consider them for comparative context: